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presenting (recombinant) cells require com-
plex co-cultivation conditions and threaten 
to contaminate the target cell population. A 
pertinent example for a specific cell activa-
tion via a membrane-bound ligand is the 
proliferation and differentiation of (anti-
body producing) B cells by interaction of 
the CD40 receptor with its physiological 
ligand, namely CD40L.[3] For a successful 
stimulation of B cells, both the presenta-
tion of CD40L as transmembrane protein 
and the in situ oligomerization into a trimer 
is assumed to be crucial.[1,4,5] Successful ex 
vivo expansion of B cells has been achieved 
using irradiated peripheral blood mononu-
clear cells (PBMCs) or recombinant cells 
acting as feeder and CD40L presenting 
cells.[4,6] However, the recombinant cells are 
not openly accessible and, most importantly, 
contamination with xenogeneic components 
limit their use for clinical applications. Therefore, a substitute 
presentation system with reduced drawbacks and efficacy compa-
rable to the natural membrane-bound CD40L is highly desirable.
Such a solution may be provided by bacterial magnetosomes, 
biogenic nanoparticles produced by magnetotactic bacteria. In 
the alphaproteobacterium Magnetospirillum gryphiswaldense they 
consist of a monocrystalline magnetite core enveloped by a lipid 
membrane, which contains a set of magnetosome-specific pro-
teins.[7,8] The particles exhibit unprecedented characteristics like 
strong magnetization, as well as uniform shape and size, which 
makes them highly attractive for biomedical and biotechnolog-
ical applications. Furthermore, magnetosomes can be geneti-
cally engineered by expression of foreign proteins as fusions 
to highly abundant magnetosome membrane (Mam) proteins. 
Using this approach, the feasibility to express antibodies, fluo-
rophores, enzymes and receptors was already demonstrated.[9,10] 
In addition to stable protein display, it can be assumed that the 
oligomerization of monomeric subunits into functional multi-
meric structures is facilitated, as recently has been shown for 
enzymes like the glucuronidase GusA or glucose oxidase.[11,12] 
The presentation of a functional multimeric ligand, such as 
CD40L, to trigger a receptor response is significantly more 
challenging because steric hindrances linked to the size of the 
interaction partners conceivably present a bottleneck. How-
ever, prompted by the current state-of-the-art we hypothesized 
that a trans-presentation of CD40L on magnetosomes might 
allow a successful trimerisation required for biological activity, 
thereby mimicking the natural membrane-bound state of the 
Cell–cell interactions involving specific membrane proteins are critical triggers 
in cellular development. Ex vivo strategies to mimic these effects currently use 
soluble proteins or (recombinant) presenter cells, albeit with mixed results. A 
promising alternative are bacterial magnetosomes, which can be selectively 
transformed into cell-free membrane–protein presenters by genetic engi-
neering. In this study, the human CD40 Ligand (CD40L), a key ligand for B cell 
activation, is expressed on the particle surface. Functionality is demonstrated 
on sensor cells expressing the human CD40 receptor. Binding of CD40L mag-
netosomes to these cells triggers a signaling cascade leading to the secretion 
of embryonic alkaline phosphatase. Concomitantly, the CD40–CD40L interac-
tion is strong enough to allow cell recovery by magnetic sorting. Overall, this 
study demonstrates the potential of magnetosomes as promising cell-free 
tools for cellular biotechnology, based on the display of membrane-bound 
target molecules, thereby creating a biomimetic interaction.
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Biological reactions triggered by the interaction of specific 
membrane-bound ligands (L) with cellular receptors are of high 
interest in tissue engineering, but also for directed stem cell dif-
ferentiation or in cancer immunotherapy.[1,2] Current approaches 
to mimic such reactions ex vivo use soluble multimers of the 
ligand or present the ligand on the surface of (genetically modi-
fied) mammalian cells. Both approaches are known to have dis-
advantages: soluble multimers are often not nearly as active as 
their natural membrane-anchored counterparts, while ligand 
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ligand. Magnetosomes allow for a feeder-free culture system, 
thereby reducing common risk in biotechnological products 
derived from cell lines such as contamination with pathogenic 
agents and/or persistence of glycoprotein molecules (shown for 
murine presenting feeder cells), which could result in severe 
immune reactions against any transplanted cell product.[13]
To study effects of ligand density, three variants of CD40L 
displaying magnetosomes were generated using two Mam pro-
teins with different abundances, namely MamC and MamG 
(60 or 165 copies per particle, respectively),[12,14] as anchors. 
A 702 bp construct encoding a flexible 17 amino acid linker 
coupled to the extracellular codon-optimized CD40L domain 
(amino acids 51–261)[15] was fused either to the mamC or 
mamG sequence, and set under the control of a transcriptional 
unit optimized for constitutive high-level magnetosome expres-
sion (Figure S1, Supporting Information).[16] mamC-cd40l or 
mamG-cd40l cassettes were transferred to the wildtype (WT) 
of M. gryphiswaldense, thereby generating strains C-CD40L 
and G-CD40L (Figure 1). As the WT still harbors native, 
unfused gene copies of mamG or mamC in equal amounts, it 
can be assumed that approximately 30 (G-CD40L, calculated 
Mw: 35.3 kDa) or 83 CD40L copies (C-CD40L, calculated Mw: 
37.9 kDa) were displayed on the surfaces of the respective par-
ticles. In addition, the mamC-cd40l expression cassette was 
inserted into the isogenic ΔmamC strain (which lacks the corre-
sponding wildtype allele). The resulting strain, ΔC-CD40L, was 
expected to display up to 165 copies of CD40L on the magneto-
some membrane.
Phenotypically, strains C-CD40L, ΔC-CD40L, and G-CD40L 
were undistinguishable from each other and from the WT 
(Figure 2). All strains biomineralized up to 70 magnetosomes 
per cell arranged in a chain-like manner. transmission electron 
microscopy (TEM) analysis of isolated CD40L-decorated magneto-
somes showed WT-like size distributions (Figure S2, Supporting 
Information) and particle diameters (40 < rh < 55 nm; Table S1, 
Supporting Information), with the magnetite cores being sur-
rounded by an electron–light organic shell (3–5 nm) representing 
the (CD40L-functionalized) magnetosome membrane.
CD40L display on the magnetosome surface was verified by 
denaturing sodium dodecyl sulfate polyacrylamide gel electropho-
resis (SDS-PAGE) with subsequent Western blotting using poly-
clonal antibodies against the CD40L extracellular domain. Protein 
bands in the expected molecular mass range were detected for 
the magnetosome membrane fractions of all three recombinant 
strains (Figure 3A). In case of C-CD40L and ΔC-CD40L additional 
bands were visible at 15 or 25 kDa, respectively, corresponding 
to the tumor necrosis factor homology domain or monomeric 
CD40L (cleaved off the membrane anchor). As the magneto-
some membrane fractions were prepared under “mildly” dena-
turing conditions, it is furthermore tempting to assume that the 
additional bands of 81 kDa (for ΔC-CD40L) and 118 kDa (for 
C-CD40L) might represent dimeric or trimeric hybrid-CD40L 
(calculated theoretical mass 114 kDa or 76 kDa, respectively), 
which would furthermore indicate the successful oligomeriza-
tion of the ligand. No bands were detected in the membrane 
preparation from WT magnetosomes, whereas for the commer-
cial soluble recombinant human CD40L (rhCD40L) reference a 
band of about 15 kDa was visible, corresponding to the predicted 
molecular mass of monomeric rhCD40L (16.3 kDa).
For testing biological activity, magnetosome “concentrations” 
of approximately 50 µg Fe mL−1 (corresponding to 2.8 × 1011 
particles per mL) were desired. The colloidal stability of such 
suspensions was estimated by dynamic light scattering (DLS). 
Hydrodynamic diameters of the CD40L magnetosome variants 
in storage buffer (10 mm 4-(2-hydroxyethyl)-1-piperazineethane-
sulfonic acid (HEPES), pH 7.0) were all in the range as 
determined by TEM and similar to non-functionalized WT 
magnetosomes (Table S1, Supporting Information), thereby 
confirming colloidal stability. In addition, the stability of all 
CD40L-functionalized magnetosomes in cell culture medium 
(Dulbecco’s modified eagle’s medium-10% fetal calf serum, up 
to 40 h incubation) was verified to exclude effects caused by 
non-specific interactions with media compounds (Figure S3, 
Supporting Information). For non-decorated WT magneto-
somes, the hydrodynamic diameter increased two-fold during 
incubation indicating the formation of small agglomerates or 
particle chains. A similar trend, though less pronounced, was 
observed for G-CD40L. In case of C-CD40L and ΔC-CD40L even 
a prolonged incubation in cell culture medium did not have a 
significant effect on the particle size. This may be due to elec-
trostatic repulsion/steric hindrance caused by the high number 
of presented ligands. CD40L magnetosomes can thus be used 
for cell culture applications at least at final concentrations 
≤ 50 µg Fe mL−1.
The biological activity of the CD40L-functionalized magne-
tosomes was first tested using recombinant human embryonic 
kidney (HEK)-CD40L sensor cells, which express the human 
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Figure 1. Magnetosome display of CD40L moieties (expressed as hybrid-
proteins on the particle surface), and formation of biologically active, tri-
meric structures (shown for MamC-CD40L). Size of particle and proteins 
not to scale.
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CD40 (hCD40) receptor on their surfaces together with an 
NF-κB-inducible SEAP (human secreted embryonic alkaline 
phosphatase). Interaction of the CD40 receptor with CD40L leads 
to the activation-correlated secretion of SEAP into the cell culture 
supernatant. SEAP was quantified in the cell culture supernatant 
using a novel assay recently described.[17] We first verified that 
the necessary addition of up to 20% (v/v) of a hypotonic 25 mm 
HEPES buffer did not significantly affect the viability of the cells 
(Table S2, Supporting Information). Subsequently, the sensor 
cells (16 × 104 cells mL−1) were incubated with 50 µL (corre-
sponding to 50 µg Fe mL−1 or 107–108 ligand molecules per cell) 
of the respective CD40L-magnetosome suspensions. As controls, 
we tested magnetosomes “decorated” with protein arrays of sim-
ilar molecular mass as CD40L (PS magnetosomes,[18] displaying 
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Figure 2. Upper panel: TEM micrographs of the M. gryphiswaldense WT and cd40l expressing strains. Lower panel: TEM micrographs of isolated 
(CD40L-functionalized) magnetosomes. The surrounding magnetosome membrane is indicated by arrows.
Figure 3. A) Qualitative analysis of CD40L display on the magnetosome surface using SDS-PAGE with subsequent Western blotting (immunochemical 
detection). Sample volumes correspond to 32 µg Fe per lane. WT magnetosomes and recombinant, soluble rhCD40L (2 µg) were used as controls. 
B) Stimulatory effects of CD40L-functionalized magnetosomes on HEK-CD40L sensor cells. WT (n = 3), PS (n = 3), G-CD40L (n = 3), ΔC-CD40L (n = 
3), and C-CD40L (n  =  2) magnetosomes as well as the corresponding particle-free supernatants (n  =  2) were tested for their ability to stimulate 
HEK-CD40L cells (16 × 104 cells mL−1). Black bars: magnetosome suspensions, white bars: corresponding supernatants. Statistically significant differ-
ences (p < 0.05) are denoted by *.
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arrays of 85 polyserine residues fused to MamC) and WT mag-
netosomes to confirm the specificity of the response. Cells 
were also incubated with 50 µL of the centrifuged magnetosome 
supernatants to exclude the presence of soluble, non-membrane 
bound CD40L released from the magnetosome membrane in 
the added suspension, Figure 3B.
As expected, neither WT nor PS magnetosomes induced 
SEAP production. In case of the magnetosome supernatants, 
only background activities were measured, indicating that 
CD40L stayed stably immobilized on the magnetosome sur-
face. By contrast, all CD40L-functionalized magnetosomes 
elicited a strong response reminiscent of cell–cell activation 
in the sensor cells. The effect of G-CD40L and ΔC-CD40L on 
the cells was similar, despite considerable differences in ligand 
density. Up to 1.6-fold more SEAP was produced when the cells 
were in contact with C-CD40L magnetosomes, suggesting that 
an optimum ligand density exists, which induces the highest 
response. Based on the frequency of the respective Mam pro-
teins, G-CD40L magnetosomes (about 30 ligands per particle) 
would theoretically allow the formation of 10 CD40L trimers. 
C-CD40L magnetosomes (83 monomers) could display up to 
27 trimers, while for ΔC-CD40L magnetosomes (165 CD40L 
monomers) a theoretical number of 55 trimers is calculated. 
The biological activity of CD40L strongly depends on the forma-
tion of these (multi)trimers.[19,20] Higher ligand densities might 
impede CD40L trimerization via steric hindrances on an “over-
crowded” surface. As mentioned above, the mean diameters of 
the magnetosomes and their size distributions were rather sim-
ilar for the three CD40L-functionalized magnetosomes. There-
fore, we can exclude magnetosome size effects.
As specifically interacting magnetic nanoparticles, magne-
tosomes are also putative capturing agents. To date they have 
mostly been used to capture soluble analytes.[9,21,22] However, 
as trimeric CD40L can be expected to bind CD40 with high 
apparent affinity in the low nm range,[23] we tested the possi-
bility of capturing entire cells using CD40L magnetosomes. 
Sensor cells were incubated with 50 µL of a CD40L-magne-
tosome suspension (25 and 50 µg Fe mL−1 in binding buffer) 
and subsequently subjected to cell sorting using magnetic 
racks. WT and PS magnetosomes as well as just 10 mm HEPES 
buffer were used as negative controls. Although full recovery 
rates of the HEK-CD40L cells could not be achieved (and addi-
tional improvements of the experimental setting might be 
required), the incubation with CD40L magnetosomes allowed 
to retain almost 50% of the cells in the magnetic field (Table 1). 
Interestingly, neither the ligand density nor the magnetosome 
concentration seemed to play a crucial role in cell recovery. 
These results show that the interaction between the immo-
bilized CD40L and its receptor is strong enough to allow for 
cell sorting. When incubated with HEPES or WT/PS magneto-
somes, less than 20% of the HEK-CD40L cells were retained.
In conclusion, we show that hCD40L functionalized mag-
netosomes can effectively bind to the corresponding cellular 
receptor and elicit biological responses, as demonstrated here 
by using SEAP secreting sensor cells as model. This proves that 
the presentation of a ligand as a membrane-anchored protein 
on the surface of magnetosomes can indeed function as a sur-
rogate for recombinant (genetically engineered) cells, which 
are the current gold standard. Our results also underline the 
potential of (ligand) functionalized magnetosomes for targeted 
magnetic cell-sorting. Since several magnetosome membrane 
anchors could be simultaneously utilized,[12] the density of dis-
played functional groups might be further adjusted over a cer-
tain range. Hence, the magnetosome display system provides 
a versatile all-in-one tool, which not only allows a highly selec-
tive, cell-free membrane-bound presentation, but also a ligand-
prompted magnetic cell sorting.
Experimental Section
Detailed information about experimental procedures is available as 
Supporting Information.
Supporting Information
Supporting Information is available from the Wiley Online Library or 
from the author.
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Table 1. Magnetic sorting of HEK-CD40L cells using functionalized 
magnetosomes.
Cell recovery [%]
50 µg Fe mL−1 magnetosomes 25 µg Fe mL−1 magnetosomes
10 mm HEPES 13.4 ± 1.3 9.8 ± 3.5
WT 15.1 ± 4.2 n.d.
PS 19.0 ± 2.9 n.d.
G-CD40L 40.1 ± 5.2 47.5 ± 4.7
C-CD40L 48.7 ± 4.4 42.2 ± 8.6
ΔC-CD40L 42.3 ± 1.6 47.7 ± 7.3
Data correspond to cells present in the magnetically retained fraction as per-
centage of the total cell number during incubation. n.d.: not determined. Data 
represent mean values ± SD for n = 2 (50 µg Fe mL−1 magnetosomes) and n ≥ 3 
(25 µg Fe mL−1 magnetosomes).
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